CASE COMMENT : UNILATERAL PRACTICES - ABUSE OF DOMINANT POSITION - PRICE REGULATION - REFUSAL TO SELL

Parallel exports of medicines : The French Competition Council issues a decision on the practices carried out by various laboratories in the area of parallel exports of medicines (Exportations parallèles de médicaments)

*This article is an automatic translation of the original article, provided here for your convenience. Read the original article. pdf/Cons._conc._dec._no_05-D-72_20_decembre_2005.pdf Facts Drug exporting companies have complained that they have been subjected to delivery restrictions, discrimination, and denial of sales by twenty-one pharmaceutical companies. They have referred the matter to the Competition Council for abuse of a dominant position by laboratories, horizontal agreements between them, and vertical agreements with their wholesaler-distributors. On 20 December 2005, the Competition Council issued a decision to dismiss the case. Decision "The Competition Council considers that it is competent to apply national law to practices implemented on the national territory and

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Author

Quotation

Marie Koehler de Montblanc, Parallel exports of medicines : The French Competition Council issues a decision on the practices carried out by various laboratories in the area of parallel exports of medicines (Exportations parallèles de médicaments), 20 December 2005, Concurrences N° 1-2006, Art. N° 27301, www.concurrences.com

Visites 1752

All reviews